Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review.

Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH.

Am J Med. 2013 Apr;126(4):357.e7-357.e27. doi: 10.1016/j.amjmed.2012.09.004. Review.

PMID:
23507208
2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

3.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204
4.

Medication adherence and the patient with coronary artery disease: challenges for the practitioner.

Maddox TM, Ho PM.

Curr Opin Cardiol. 2009 Sep;24(5):468-72. doi: 10.1097/HCO.0b013e32832ed62d. Review.

PMID:
19550308
5.

Pharmacoeconomic impact of non-compliance with statins.

Peterson AM, McGhan WF.

Pharmacoeconomics. 2005;23(1):13-25. Review.

PMID:
15693725
6.

[Stable coronary artery disease--invasive treatment does not replace secondary prevention].

Kettunen R, Lepojärvi M, Laine M.

Duodecim. 2012;128(7):720-7. Review. Finnish.

PMID:
22612022
7.

Is a statin as part of a polypill the answer?

Robinson JG.

Curr Atheroscler Rep. 2009 Jan;11(1):15-22. Review.

PMID:
19080723
8.

A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group.

Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, Peterson AM; ISPOR Medication Adherence Good Research Practices Working Group..

Value Health. 2013 Jul-Aug;16(5):891-900. doi: 10.1016/j.jval.2013.04.014. Epub 2013 Jul 10. Review.

9.

Non-adherence to statin therapy: a major challenge for preventive cardiology.

Bates TR, Connaughton VM, Watts GF.

Expert Opin Pharmacother. 2009 Dec;10(18):2973-85. doi: 10.1517/14656560903376186. Review.

PMID:
19954271
10.
11.

The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review.

Simpson RJ Jr, Mendys P.

J Clin Lipidol. 2010 Nov-Dec;4(6):462-71. doi: 10.1016/j.jacl.2010.08.026. Epub 2010 Sep 8. Review.

PMID:
21122692
12.

Secondary prevention of ischaemic cardiac events.

Gami A.

Clin Evid. 2006 Jun;(15):195-228. Review. No abstract available.

PMID:
16973010
13.

[Cost-effectiveness of coronary heart disease prevention].

Wendland G, Klever-Deichert G, Lauterbach K.

Z Kardiol. 2002;91 Suppl 2:49-60. Review. German.

PMID:
12436765
14.

Strategies to enhance cardiovascular disease prevention in patients with diabetes.

Anselmino M, Rydén L.

Curr Opin Cardiol. 2009 Sep;24(5):461-7. doi: 10.1097/HCO.0b013e32832ec3c5. Review.

PMID:
19574921
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

16.

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.

Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G.

Eur Heart J. 2006 Nov;27(22):2667-74. Epub 2006 Oct 19. Review.

PMID:
17053008
17.

New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.

Bauer SM, Cayne NS, Veith FJ.

J Vasc Surg. 2010 Jan;51(1):242-51. doi: 10.1016/j.jvs.2009.08.087. Epub 2009 Dec 2. Review.

18.

[Role of adherence to long-term drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document].

Volpe M, Degli Esposti L, Romeo F, Trimarco B, Bovenzi FM, Mastromarino V, Battistoni A.

G Ital Cardiol (Rome). 2014 Oct;15(10 Suppl 1):3S-10S. doi: 10.1714/1696.18514. Italian.

PMID:
25426833
19.

A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model.

AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM.

J Clin Hypertens (Greenwich). 2012 Dec;14(12):877-86. doi: 10.1111/j.1751-7176.2012.00699.x. Epub 2012 Aug 20. Review.

20.

Aspirin for cardioprotection and strategies to improve patient adherence.

Duffy D, Kelly E, Trang A, Whellan D, Mills G.

Postgrad Med. 2014 Jan;126(1):18-28. doi: 10.3810/pgm.2014.01.2721. Review.

PMID:
24393748

Supplemental Content

Support Center